P21 10mg

P21, also known as P021, is a synthetic tetrapeptide derived from the active region of Ciliary Neurotrophic Factor, CNTF.

It was developed as a smaller and more stable CNTF mimetic for laboratory research into neuroprotection, neurogenesis, synaptic plasticity and cognitive function.

P21 is mainly studied in Alzheimer’s-related models, brain ageing research, memory studies and neurodegenerative research.

How It Works

P21 is studied for its effect on neurotrophic signalling pathways involved in brain repair, neuronal growth and cell protection.

Research suggests that P21 may inhibit LIF, Leukaemia Inhibitory Factor, signalling, which may help increase BDNF, Brain-Derived Neurotrophic Factor, expression.

BDNF plays an important role in neurogenesis, synaptic plasticity, learning, memory and neuronal resilience in research models.

P21 has also been studied for its potential role in reducing tau hyperphosphorylation and amyloid-beta accumulation in Alzheimer’s-related research models.

In simple terms, P21 is being studied for its potential to support brain-cell communication, repair and protection in controlled laboratory settings.

Observed Benefits

Research interest in P21 includes:

• Cognitive function and memory support in research models.
• Support for neurogenesis, the formation of new neurons.
• Support for synaptic plasticity, which is linked to learning and memory adaptation.
• Potential reduction in tau hyperphosphorylation.
• Potential reduction in amyloid-beta accumulation.
• Neuroprotective effects under cellular and neurological stress.

In short, P21 is an interesting research peptide for brain ageing, Alzheimer’s-related models, memory and neuroprotection.

Possible Side Effects

Published safety data on P21 remains limited, especially in human contexts.

In available animal research, P21 appears to be generally well-tolerated, but long-term safety has not been established.

Possible concerns include:

• Limited adverse-event data.
• No established long-term safety profile.
• No approved medical use.
• Unknown effects outside controlled laboratory research settings.

Bottom line: P21 remains an investigational compound and should be handled strictly as a laboratory research material.

Reconstitution, Dosage and Cycling, Research Only

P21 is typically reconstituted with bacteriostatic water under controlled laboratory conditions.

There are no approved human or animal dosing guidelines for P21.

Research dosages reported in studies are generally low microgram-level quantities in animal models, depending on the study design, model type, route and research objective.

No standard research cycle has been established.

Researchers should follow validated study protocols, sterile laboratory handling procedures and applicable institutional safety guidelines.

For research purposes only. Not for human or animal consumption.

Fun Facts

• P21 was developed as a smaller and more stable mimetic of CNTF.
• CNTF has long been studied for neuronal survival and repair.
• Full-length CNTF has been associated with unwanted effects such as weight loss, which made smaller mimetics more interesting to researchers.
• P21 is strongly linked to BDNF research, one of the brain’s most important growth and repair signals.
• P21 is mainly studied in Alzheimer’s, memory, brain ageing and neuroplasticity models.

Citations and Sources

Most available P21 research is preclinical, with strong interest in neurodegenerative and Alzheimer’s-related models.

Key research areas include:

1. CNTF-derived peptide mimetic research.
2. BDNF expression and neurogenesis pathways.
3. Tau hyperphosphorylation and amyloid-beta research models.
4. Synaptic plasticity and cognitive-function studies.
5. Neuroprotection under cellular and neurological stress.

Takeaway: P21 shows promising preclinical research signals, but more research is needed before any safety, treatment or human-use conclusions can be made.

Our Take

P21 is one of the more interesting cognitive and neuroprotective research peptides, especially for Alzheimer’s-related models, memory, brain ageing and neuroregeneration studies.

Its connection to BDNF, neurogenesis, synaptic plasticity, tau and amyloid-beta research makes it a strong addition to advanced brain-health research categories.

Promising, but still early-stage and strictly research-only.

Disclaimer

Important disclaimer upfront: P21, also known as P021, is not approved by SAHPRA, the FDA, or any major regulatory authority for medical use.

This product is sold strictly for laboratory research purposes only. It is not intended for human or animal consumption, diagnosis, treatment, prevention, or cure of any disease. The information provided is for educational and research context only and should not be interpreted as medical advice.